Abstract: An unmanned charging device and method for a smart logistics vehicle are disclosed. The unmanned charging device includes a charging body configured to enable a mobile robot to dock therewith and having an inner space, and a charging terminal unit inserted into the inner space of the charging body and having a front support at a front side thereof, the charging terminal unit being configured to enable charging of the mobile robot. When the mobile robot approaches the charging body in response to reception of a charging request, a sensing unit of the mobile robot is supported by the front support, thereby causing the mobile robot to be adjusted in position. Docking of the mobile robot with the charging terminal unit is performed in a position-adjusted state of the mobile robot.

Abstract: Example embodiments include an aerogel composition for battery insulation sheets, the aerogel composition including an aerogel, a functional material including a binder, a dispersant, or a combination thereof, a flame retardant including a phosphorus-based material, and a solvent. Example embodiments also include a method of manufacturing the aerogel composition, a battery insulation sheet formed using the aerogel composition, and a battery module including the aerogel composition.

Abstract: Provided is a system for estimating oxygen saturation by using a photoplethysmography (PPG) signal sensing ring.

Abstract: Example embodiments include an aerogel composition for battery insulation sheets, the aerogel composition including an aerogel, a functional material including a binder, a dispersant, or a combination thereof, and a solvent. The binder includes a first binder including an aqueous polymer binder and a second binder including a fluorocarbon-based binder. Example embodiments also include a method of manufacturing the aerogel composition, a battery insulation sheet formed using the aerogel composition, and a battery module including the aerogel composition.

Abstract: Provided is a method for areal selective forming of a thin film according to an exemplary embodiment of the present disclosure including: a substrate preparation step of supplying and stabilizing a substrate including a growth area and a non-growth area into a chamber; a precursor supply step of supplying a metal precursor compound into the chamber and adsorbing the metal precursor compound to the substrate; a purge step of purging the inside of the chamber; and a thin film formation step of supplying a reaction material into the chamber to react with the metal precursor compound and form a thin film, in which the metal precursor compound is a Group 5 metal precursor compound represented by Chemical Formula 1 below:

Abstract: An additive for an electrolyte solution of a secondary battery includes a microcapsule particle. The microcapsule particle includes a core containing a phosphorus-based flame retardant, and a shell surrounding a surface of the core and including a polymer that includes a urea-derived repeating unit, a formaldehyde-derived repeating unit and a resorcinol-derived repeating unit. An electrolyte solution and a lithium secondary battery including the additive for an electrolyte solution have improved stability, life-span and storage properties at high temperature.

Abstract: A battery insulation sheet including an aerogel layer. The aerogel layer includes: a fibrillized polymer matrix comprising a dry binder; and aerogel particles distributed in the fibrillized polymer matrix.

Abstract: A valve assembly for controlling charging and discharging of a fuel prevents a high pressure charging pressure from being applied to a solenoid valve during fuel charging. The valve assembly includes a transfer flow passage composed of: a charging/discharging flow passage; a charging flow passage branched from the charging/discharging flow passage and connected to a storage tank; and a discharging flow passage branched from the charging/discharging flow passage and connected to the storage tank. Further, the valve assembly includes a first check valve configured to prevent backflow of the fuel transferred along the charging flow passage; a solenoid valve configured to open or close the discharging flow passage to regulate flow of the fuel; a second check valve configured to prevent backflow of the fuel transferred along the discharging flow passage; and a metering valve configured to control a flow rate of the fuel transferred along the discharging flow passage.

Abstract: A body including a dielectric layer and internal electrodes disposed alternately with the dielectric layer interposed therebetween; and external electrodes disposed on the body, wherein the dielectric layer includes a main component containing calcium (Ca), strontium (Sr), zirconium (Zr) and titanium (Ti) and a sub-component containing manganese (Mn), yttrium (Y) and silicon (Si), wherein the dielectric layer includes a plurality of dielectric grains and grain boundaries disposed between adjacent dielectric grains, and at least a portion of the plurality of dielectric grains has a core-shell structure, a content of yttrium (Y) included in a core relative to 100 moles of zirconium (Zr) included in the core and a shell is defined as Yc, a content of yttrium (Y) included in the shell relative to 100 moles of zirconium (Zr) included in the core and the shell is defined as Ys, and Ys/Yc>9 is satisfied.

Abstract: A battery insulation sheet includes a substrate, and an aerogel layer on the substrate, wherein the aerogel layer includes a fibrous support; an aerogel; and a functional material including a binder, a dispersant, or a combination thereof, and satisfies Formula 1 below: 50 ? A ? 100 , 000 , A = T i / D s , Formula ? 1 wherein, in Formula 1, Ti denotes a thickness of the aerogel layer, and Ds denotes an average diameter of the fibrous support.

Abstract: An aerogel composition for a battery insulation sheet, a method of preparing the same, a battery insulation sheet formed using the same, and a method of manufacturing the battery insulation sheet are provided herein. The aerogel composition includes a solvent, a fibrous support, an aerogel, an antifoaming agent, and a functional material including a binder, a dispersant, or a combination thereof, wherein the fibrous support is 5 wt % to 70 wt %, the aerogel is 10 wt % to 90 wt %, the antifoaming agent is 0.05 wt % to 2 wt %, and the functional material is 0.5 wt % to 20 wt %, with respect to a total solid amount of the aerogel composition.

Abstract: An aerogel composition for a battery insulation sheet is provided. The aerogel composition comprising: a solvent; a fibrous support; an aerogel; and a functional material including a binder, a dispersant, or a combination thereof. With respect to a total solid content of the aerogel composition, the fibrous support is present in a content range of 5 wt % to 70 wt %, the aerogel is present in a content range of 10 wt % to 90 wt %, and the functional material is present in a content range of 0.5 wt % to 20 wt %.

Abstract: A roller for supporting a material according to an embodiment of the present invention includes: a rotation shaft; a pipe having a space in which the rotation shaft is inserted; a deforming part that is connected to the rotation shaft and the pipe to deform the pipe; and a support part that is installed at the pipe to support the material. The deforming part includes: a thread portion provided on the rotation shaft; a nut part screwed to the thread portion; an inclined part that is disposed at an inner surface of the pipe and that is pressed by the nut part according to rotation of the rotation shaft; and a driving source that is connected to the rotation shaft to rotate the rotation shaft.

Abstract: An etching composition contains phosphoric acid, phosphoric anhydride, a compound represented by the following Formula 1, and a silane compound comprising at least one silicon (Si) atom, excluding the compound represented by Formula 1: wherein, in Formula 1, A is an n-valent radical, where n is an integer of 1 to 6, L is a direct bond or hydrocarbylene, Y is selected from NR1, O, PR2 and S, where R1 to R2 are independently hydrogen, halogen, a substituted or unsubstituted hydrocarbyl group, or non-hydrocarbyl group, X and Z are independently selected from N, O, P and S, and Ra to Rc are independently an unshared electron pair, hydrogen, or a substituted or unsubstituted hydrocarbyl group.

Abstract: The present invention pertains to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease, the composition containing G protein coupled receptor 119 (GPR119) ligand as an active ingredient. The pharmaceutical composition according to the present invention exhibits the excellent effects of improving lipid metabolism, reducing fat accumulation in liver tissues, and preventing histological damage caused by inflammation and fibrosis in liver tissues, and can thus be useful in preventing or treating non-alcoholic fatty liver disease.

Abstract: One aspect of the present disclosure relates to a pharmaceutical composition for treating triple negative breast cancer, containing, as an active ingredient, a novel non-natural nucleic acid ligand that binds to both human serum albumin (HSA) and a G12D-mutation KRAS protein. The pharmaceutical composition exhibits an excellent effect on the treatment of primary or metastatic triple negative breast cancer, which is difficult to treat. In addition, one aspect of the present disclosure relates to a novel non-natural nucleic acid ligand binding to both human serum albumin (HAS) and a G12D-mutation KRAS protein, and a use thereof. The novel nucleic acid ligand may comprise a nucleic acid sequence of SEQ ID NO: 11 (GNA6AAG6CCGGA6GGCAGC666A6GC) [wherein, the second nucleic acid N is cystidine or gemcitabine and the part represented as 6 is 5-[N-(1-naphthylmethyl) carboxamide]-2?-deoxyuridine (Nap-dU)].

Abstract: One aspect of the present disclosure relates to a novel non-natural nucleic acid ligand that binds to human serum albumin (HSA), and to uses thereof. The novel non-natural nucleic acid ligand may include the nucleic acid sequence of SEQ ID NO: 8 (CAGG6CGAGC6G6ACGCG6G6G6GACC) [wherein the moiety indicated by 6 is 5-[N-(1-naphthylmethyl)carboxamide]-2?-deoxyuridine (Nap-dU)]. Meanwhile, one aspect of the present disclosure relates to a pharmaceutical composition for treating cancer, comprising a novel non-natural nucleic acid ligand that binds to human serum albumin as an active ingredient. The pharmaceutical composition exhibits excellent effects in the treatment of cancer.

Abstract: The cathode active material for a lithium secondary battery according to embodiments of the present invention includes lithium-transition metal composite oxide particles including a plurality of primary particles, and the lithium-transition metal composite oxide particles have a lithium-potassium-containing portion formed between the primary particles. Thereby, it is possible to improve life-span properties and capacity properties by preventing the layer structure deformation of the primary particles and removing residual lithium.

Abstract: The present disclosure relates to a display device capable of performing a touch input by a touch input device, and a touch input system including the same. According to an embodiment of the disclosure, a display device comprising a display unit comprising a plurality of emission areas, a plurality of touch electrodes disposed between the plurality of emission areas to sense a touch, a plurality of code patterns formed by covering a part of a front surface of at least one of the plurality of touch electrodes with a predetermined code shape, and a plurality of light-blocking patterns formed on at least one of the plurality of touch electrodes on which the plurality of code patterns is not formed, to block light, wherein the plurality of light-blocking patterns is formed by covering at least one of a front surface and side surfaces of the at least one touch electrode with a predetermined pattern shape.

Abstract: The present invention relates to a novel compound that induces selective degradation of AURKA, and specifically provides a bifunctional compound in which an AURKA binding moiety and an E3 ubiquitin ligase binding moiety are linked by a chemical linker, a method for preparing same, and a use thereof. In addition, the compound according to the present invention can be effectively used for the prevention or treatment of AURKA-related diseases.